Warning! The directory is not yet complete and will be amended until the beginning of the term.
322571 VU Technological and Biopharmaceutical Aspects of Biologics - M7/M14 (2024S)
Continuous assessment of course work
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Mo 25.03.2024 12:00 to Fr 12.04.2024 12:00
- Deregistration possible until Fr 12.04.2024 12:00
Details
Language: English
Lecturers
Classes
Monday April 22th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Tuesday April 23th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Wednesday April 24th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Thursday April 25th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Friday April 26th, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Thursday May 2rd, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
Friday May 3rd, 2024 - 9:45 a.m. - 11:15 a.m. 2F161
The number of participants is limited.
Information
Aims, contents and method of the course
Assessment and permitted materials
Shelf life prediction calculation exercise (50% of total mark)
Pharmacokinetics calculation exercise (50% of total mark)
Pharmacokinetics calculation exercise (50% of total mark)
Minimum requirements and assessment criteria
A minimum of total of 50% in each of the assessment exersices will be necessary to pass this course.
Examination topics
Reading list
Wang & Ohtake, Science and art of protein formulation development. International Journal of Pharmaceutics (2019) 568:118505
https://doi.org/10.1016/j.ijpharm.2019.118505Anselmo, Gokarn & Mitragotri, Non-invasive delivery strategies for biologics. Nature Reviews Drug Discovery (2019) 18:19–40
https://doi.org/10.1038/nrd.2018.183Rugo et al., Demystifying biosimilars: development, regulation and clinical use. Future Oncology (2019) 15
https://doi.org/10.2217/fon-2018-0680
https://doi.org/10.1016/j.ijpharm.2019.118505Anselmo, Gokarn & Mitragotri, Non-invasive delivery strategies for biologics. Nature Reviews Drug Discovery (2019) 18:19–40
https://doi.org/10.1038/nrd.2018.183Rugo et al., Demystifying biosimilars: development, regulation and clinical use. Future Oncology (2019) 15
https://doi.org/10.2217/fon-2018-0680
Association in the course directory
MA8, MA23
Last modified: We 10.04.2024 13:46
- Knowledge of formulation principles for biotech products
- Challenges of protein formulations (addressing challenges through preformulation)
- Knowledge of formulation processes and ingredients
- Knowledge of drug delivery mechanisms and kinetics
- Knowledge of parenteral controlled release formulations
- Knowledge of the basic concepts of Pharmacokinetics
- Overview on the pharmacokinetic models
- Knowledge concerning the relevant pharmacokinetic parameters
- Basics of the physiological background of the Pharmacokinetics
- Application of the pharmacokinetic evaluation on selected drugs